Human Recombinant NAP-2 (from E. coli)
Supplier: Shenandoah Biotechnology
New Product
Certificates
About this item
Neutrophil activating peptide 2 (NAP-2), also known as CXCL7, is a member of the CXC family of chemokines. NAP-2 is a carboxyl-terminal fragment produced by proteolytic cleavage of the platelet basic protein (PBP). NAP-2 is released from platelets and binds to the receptors CXCR1 and CXCR2 to chemoattract and activate neutrophils during inflammatory events.
- High quality
- Low endotoxin
- Affordable
Caution: For research use only.
Specifications
- Coniugazione:Non coniugato
- Protein function:Cytokine
- Protein/peptide type:Recombinant
- Sorgente luminosa:E. coli
- Specie:Human
- Condizioni di conservazione:–20 °C
- Contenuto di endotossine:Endotoxin LAL (EU/µg) ≤0,1
- Attività biologica:Bioactivity: No biological activity data is available at this time
- ID gene:P02775
- Ricostituzione:Sterile water at 0,1 mg/ml
- Privo di endotossine:N
- Senza corriere:Y
- Protease-free:N
- Senza animali:N
- Protein synonyms:Platelet basic protein|MDGF|LDGF|PBP|CXCL7, Neutrophil activating peptide 2|PPBP
- Protein/peptide name:NAP-2
- Purezza:≥95%
- Peso molecolare:7,6 kDa
- Sequenza:AELRCMCIKT TSGIHPKNIQ SLEVIGKGTH CNQVEVIATL KDGRKICLDP DAPRIKKIVQ KKLAGDESAD
- Livello di endotossine:Low
- Formulazione:10 mM Sodium phosphate, pH 7,5
- Esente da nucleasi:N
- Grado:RUO
- Temperatura di spedizione:RT
Specifications
Frequently Bought Together